Clik here to view.
PharmaCyte Biotech Completes Final cGMP Audit of Manufacturing Facility for...
LAGUNA HILLS, Calif. PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation...
View ArticleClik here to view.
Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis...
LEIDEN, Netherlands & MADISON, Wis. Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System (OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in...
View ArticleClik here to view.
メアリー・ケイがCOVID-19パンデミックの救援活動と最前線従事者の支援としてアジア太平洋地域で手指消毒剤を寄付
ダラス （ビジネスワイヤ） — メアリー・ケイ・アジア太平洋は、COVID-19の世界的流行が与える前例のない影響に対処する救援活動の支援として、アジア太平洋地域で絶対的に必要とされている手指消毒剤の寄付と配布を行うと発表しました。...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Completes the Acquisition of Select Business...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announces that it has completed the acquisition of select divisions of Wockhardt Limited’s...
View ArticleClik here to view.
Takeda Selects Two New Partners for Annual Global Corporate Social...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced the addition of two partners to its Global Corporate Social Responsibility (CSR) Program, which...
View ArticleClik here to view.
武田薬品：グローバルCSRプログラムにおける2つの新たなパートナーを選定し、途上国での医療制度の強化と医療へのアクセス向上を支援
大阪 （ビジネスワイヤ） — 当社は、このたび、グローバルCSRプログラムにおける支援先として、Access to Health FundとBridges to...
View ArticleClik here to view.
Takeda to Divest OTC and Select Non-core Assets in Asia Pacific to Celltrion...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter...
View ArticleClik here to view.
Celltrion’s Subsidiary Acquires Primary Care Product Assets for Asia Pacific...
INCHEON, South Korea Celltrion (KRX:068270) announced today that it has signed an agreement to acquire product assets for the Asia Pacific region from Takeda Pharmaceuticals International AG...
View ArticleClik here to view.
宝洁美尚事业部在全球启动Responsible Beauty“尽责 尽美“项目
CINCINNATI 在人类社会面临诸多挑战的今天，创造可持续发展的世界显得尤为重要。作为行业领军者，宝洁美尚事业部在改善人类生活质量和保护环境方面，一直致力于成为一股向上和向善的力量。2020年6月8日，宝洁美尚事业部宣布在全球启动Responsible Beauty“尽责...
View ArticleClik here to view.
CGTN: Super Virus – COVID-19: How We Got Here
BEIJING The novel coronavirus has so far claimed over 400,000 lives worldwide, according to John Hopkins University. No one knows how dangerous the virus really is and how long the pandemic will...
View ArticleClik here to view.
发挥《WELL 健康 – 安全评价准则》之威力，IWBI加强对酒店及度假村服务力度
纽约 (美国商业资讯)–全球领先的健康建筑认证机构国际WELL建筑研究院（IWBI）今日宣布成立专门针对酒店及度假村产业的WELL顾问委员会，为IWBI刚刚推出的《设施与运营管理WELL 健康 – 安全评价准则》提供极具针对性的行业洞察及指导建议。这是一套建立在循证研究基础上、由第三方独立验证的评价准则，适用于全球所有类别物业在COVID-19...
View ArticleClik here to view.
武田选定两家新合作伙伴加入年度全球企业社会责任(CSR)计划，以帮助发展中国家建立强大的卫生体系，让人们更好地享有医疗服务
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)...
View ArticleClik here to view.
武田以高达2.78亿美元的价格向Celltrion剥离亚太地区的OTC和选定的非核心资产
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布已达成协议，将仅在亚太地区出售的选定非核心非处方药(OTC)和处方药组合出售给Celltrion Inc....
View ArticleClik here to view.
CGTN：スーパーウイルス – COVID-19：ここまでの道のり
北京 （ビジネスワイヤ） — ジョンズ・ホプキンス大学によれば、新型コロナウイルスはこれまでに世界で40万人を超える命を奪ってきました。このウイルスが実際どの程度危険であるのか、いつまでパンデミックが続くのかということは、誰にも分かっていません。...
View ArticleClik here to view.
Clik here to view.
台湾AI、IoT、Sensor、8K、5G关键技术 助全球疫后加速数字医疗转型
台北 疫情新常态，全球数字医疗应用升级与转型需求剧增！台湾第一季电子业生产制造、半导体出货持续在全球维持正成长，成为全球医疗科技最稳健合作伙伴。2020台湾医疗科技展(2020.12.3-6)，由300家一线科技大厂联合医疗体系共同展出，完整展现AI、IoT、Sensor、8K显示技术以及5G通讯传输等医疗、健康照护的最新应用，向全球展秀医疗科技如何带来新生活、新经济型态。...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
HYDERABAD, India Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements...
View ArticleClik here to view.
CureApp Awarded as Technology Pioneer by World Economic Forum
TOKYO CureApp, a Tokyo-based company that develops “Digital Therapeutics (DTx),” was selected among hundreds of candidates as one of the World Economic Forum’s “Technology Pioneers”. CureApp,...
View ArticleClik here to view.
Taiwan Prepared for the Post-Covid-19 Era With Emerging Technologies
TAIPEI, Taiwan The Covid-19 pandemic spurs transformation of digital healthcare everywhere. To echo that trend, the Healthcare+ Expo Taiwan will bring together 300 technology giants and healthcare...
View ArticleClik here to view.
CureApp入选世界经济论坛技术先锋
东京 (美国商业资讯)–总部位于东京、开发“数字疗法(DTx)”的公司CureApp在数百家候选者中脱颖而出，入选世界经济论坛“技术先锋”之一。由Kohta Satake MD/MPH/MBA和Shin Suzuki MD创立的CureApp是一家领先的数字治疗公司，旨在通过研发临床应用程序，运用软件来重新演进“治疗学”的未来。...
View Article